Navigation Links
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Date:8/27/2008

should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, increased intracranial pressure, papilledema, and GI perforation.

In patients with HES and cardiac involvement, cases of cardiogenic shock/left ventricular dysfunction have been associated with the initiation of imatinib therapy. The condition was reported to be reversible with the administration of systemic steroids, circulatory support measures, and temporarily withholding imatinib. MDS/MPD disease and systemic mastocytosis may be associated with high eosinophil levels. Performance of an echocardiogram and determination of serum troponin should therefore be considered in patients with HES/CEL, and in patients with MDS/MPD or ASM associated with high eosinophil levels. If either is abnormal, the prophylactic use of systemic steroids (1-2 mg/kg) for 1-2 weeks concomitantly with imatinib should be considered at the initiation of therapy.

Bullous dermatologic reactions (eg, erythema multiforme and Stevens- Johnson syndrome) have also been reported. In some cases, the reaction recurred upon re-challenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of the bullous reaction.

Consider potential toxicities-specifically liver, kidney and cardiac toxicity, and immunosuppression from long-term use.

Gleevec is metabolized by the CYP3A4 isoenzyme and is an inhibitor of CYP3A4, CYP2D6 and CYP2C9. Dosage of Gleevec should increase by at least 50%, and clinical response should be carefully monitored, in patients receiving Gleevec with a potent CYP3A4 inducer such as rifampin or phenytoin. Examples of commonly used drugs that may significantly interact with Gleevec include ketoconazole, ac
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
2. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
5. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
9. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
10. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
11. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 This ... perspectives on nonclinical and clinical safety assessment in ... to guide a path for biosimilar drug development, ... demonstration of biosimilarity with regards to quality, safety ... aspects of biosimilar drug development and registration, development ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory ... One of these latent viruses is the Epstein Barr ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... the theory, a study found that RA patients have ... , What is Microcompetition? , Dr. Hanan Polansky ...
(Date:1/15/2014)... AudioNotch is the internet's leading ... for the treatment of tinnitus. Patients listen to ... frequency, and over a period of weeks to months, ... Notched Sound Therapy in two forms: Notched Music and ... to release of a new form of Tailor-Made Notched ...
(Date:1/14/2014)... Diego, CA (PRWEB) January 14, 2014 ... solutions based on the products of cells grown ... have entered into an international license agreement with ... Histogen’s proprietary multipotent cell conditioned media (CCM). ... the existing license between Histogen and Suneva Medical, ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... SAN DIEGO, April 10 MedImmune today announced ... oncology,portfolio programs at the Annual Meeting of the ... commitment to,excellence in oncology research., "Cancer research ... at MedImmune and we,are proud to share data ...
... -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider ... General Meeting originally scheduled for March 25, 2008 ... During the April 8, 2008 Annual General ... Shangdi Xi Rd., Haidian District, Beijing,PRC, resolutions for ...
... CHICAGO, April 10 Advanced Life Sciences,Holdings, Inc. ... on a productive,meeting with the U.S. Food and ... New Drug Application (NDA) in the third quarter ... to treat mild-to-moderate,community acquired pneumonia (CAP)., (Logo: ...
Cached Biology Technology:MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 2MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 3Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 2Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 3
(Date:4/15/2014)... The global experts who study the deadliest infectious diseases ... G. Ksiazek, professors at the University of Texas Medical ... annual International Symposium on Filoviruses. The filoviruses include Ebola ... 90 percent of people infected. The current outbreak of ... than 100 deaths so far. , "This award ...
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... of Adelaide research into parasites of cuttlefish, squid ... astonishing life cycles, and shown how they may ... Researcher Dr Sarah Catalano has described 10 new ... the kidneys of cephalopods (cuttlefish, squid and octopus). ... to be described from Australian waters. , ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Bizarre parasite may provide cuttlefish clues 2
... anti-cancer drugs block the enzymes that snip the kinks and ... cells but the drugs are increasingly encountering resistant bacteria ... Berkeley, biochemists could pave the way for new research into ... poisons for cancer cells and harmful bacteria. "The development ...
... foods is a top priority in tackling the obesity epidemic ... six months, the Institute of Medicine, United States Department of ... taken an interest in improving access to affordable and nutritious ... of epidemiology, and his team are tackling the same issue. ...
... Institute for Brain Science announced today that it has launched ... charting genes at work throughout the human brain. The ... extensive and detailed body of information about gene activity in ... or "turned on" where. In the coming years, the ...
Cached Biology News:Preventing cells from getting the kinks out of DNA 2Preventing cells from getting the kinks out of DNA 3Obesity remains an economic issue, Seattle obesity study finds 2Obesity remains an economic issue, Seattle obesity study finds 3Allen Institute for Brain Science launches Allen Human Brain Atlas 2Allen Institute for Brain Science launches Allen Human Brain Atlas 3
Intestinal Epithelium Differentiation Environment...
...
The Programmable MP-5000P-F Power Supply can be applied for any Microfluidic application....
... Drummond Scientific has a long and ... microinjection apparatus. Several years ago we ... displacement microdispenser was being modified to ... unit by redesigning the microdispenser to ...
Biology Products: